Based on NHANES data collected from cancer survivors, the authors of a review found that the use of supplements was linked to long-term, cost-effective benefit.
Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.